• 검색 결과가 없습니다.

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades

N/A
N/A
Protected

Academic year: 2021

Share "Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades"

Copied!
13
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Metastatic evidence of peritoneal and distant metastases StageAnatomyMCWNCCN (2019)MDACCAHPBA/SSO/SSAT ResectableArtery  (CA, SMA, or HA)No involvementNo involvementNo involvement No involvement  Vein (SMV, PV, or  SMV-PV confluence)- No involveme
Table 2. Selected clinical trials of neoadyuvant therapy for resectable pancreatic cancer Author Year N  Neoadjuvant regimen Resected
Table 3. Selected ongoin trials of neoadyuvant therapy for RESECTABLE PDAC Trial (ID) author Phase Target

참조

관련 문서

– Step 3: substitute the element trial solution into integrals (LHS) – Step 4: Develop specific expression for the element trial

In order to decrease the deaths caused by cancer that is a serious threat to the health of many individuals living in Jejudo, it is important to

confidence intervals of pancreatic cancer incidence by increase of total cholesterol levels (10 mg/dL) during the past 3 years; Table S2: Multivariable odds ratios and

This study aimed to demonstrate the accuracy of preoperative staging of locally advanced gastric cancer using data from a large-scale randomized clinical trial.. Materials

Patients with breast cancer; ovarian cancer; renal cell carcinoma; pancreatic neuroendocrine cancer; colorectal cancer; head and neck cancer; non-small cell lung

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)..

Postoperative adhesion formation and reproductive outcome using interceed ® after ovarian surgery: a randomized trial in the rabbit model.. Adhesion reformation

Objective :::: The neovascularization is an essential a factor for the growth of solid organ cancer, and especially vascular endothelial growth factor (VEGF)